ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3250

Systemic Inflammation and Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Study

Tuhina Neogi1, Laura Frey-Law2, Devyani Misra1, Michael C. Nevitt3, Lars Arendt-Nielsen4, Emily K. Quinn5 and Cora E. Lewis6, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2UIowa, Iowa City, IA, 3Epidemiology and Biostatistics, UCSF, San Francisco, CA, 4Aalborg University, Aalborg, Denmark, 5Data Coordinating Center, Boston University School of Public Health, Boston, MA, 6Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adipokines, inflammatory arthritis, Osteoarthritis, pain and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 11, 2015

Title: Pain: Clinical Aspects

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose:
Pain sensitization is associated with pain severity in knee osteoarthritis
(OA), but its cause in humans is not well-understood. We recently demonstrated
that local inflammation at the joint could lead to pain sensitization. Whether
inflammation systemically could do the same is not known, and data from animal
models are sparse. Knee OA, considered to be a state of potentially low-grade
inflammation, is also associated with obesity, which itself can contribute to
systemic inflammation through elaboration of adipokines such as leptin and
adiponectin, which are expected to have opposite effects to one another. We
therefore evaluated whether systemically measured inflammatory cytokines and/or
adipokines may be related to pain sensitization in knee OA.

Methods: Participants
from the Multicenter Osteoarthritis (MOST) Study, a NIH-funded longitudinal
prospective cohort of persons with or at risk of knee OA, had plasma stored and
standardized pressure pain threshold (PPT) at the wrist and patellae assessed
at the 60-month visit. PPT was assessed with an algometer (1 cm2 tip,
0.5 Kg/sec) as the point at which the subject felt the pressure change to
slight pain. Lower PPT indicates more sensitivity. We measured TNF-α
(Linco multiplex), leptin and total adiponectin (R&D ELISA for both) from a
random sample of participants who were free of knee replacement.  We evaluated
the sex-specific cross-sectional relation of each inflammatory marker to PPT
using linear regression (PPT was normally distributed) with GEE to adjust for
correlations between two knees within a person, adjusting for relevant
potential confounders (age, race, BMI, pain medications, depressive symptoms,
radiographic knee OA (ROA) in either knee). We repeated analyses stratified by
ROA status.

Results: There
were 750 subjects randomly selected from the 60-month MOST study visit among
those who had bilateral native knees (mean age (SD) 66.8 (7.6), mean BMI 30.3
(5.8), 58% female, 44.8% knees with radiographic knee OA). Plasma levels of TNF-α
were not associated with PPT at either site (Table). Leptin and total adiponectin
were both associated with lower PPT at the patella (more sensitized), while
there was no association at the wrist. The results were similar among those
with and without ROA.

Conclusion:
Although a general marker of systemic inflammation (TNF-α) does not
appear to be associated with pain sensitization, adipokines may be associated
with increased pain sensitization and/or sensitivity at the knee. While we
expected adiponectin to have an association opposite to that of leptin, total
adiponectin may not be an accurate reflection of adiponectin’s biologically
active form. Nonetheless, the finding of similar effects of these two
adipokines on pain sensitization requires further study.

 

Table: Relation of inflammatory markers to PPT

Inflammatory Marker

PPT: Adjusted standardized beta (95% CI)

Men

Women

Patella

Wrist

Patella

Wrist

TNF-α

-0.02 (-0.16, 0.11)

-0.05 (-0.20, 0.10)

-0.14 (-0.31, 0.02)

-0.14 (-0.29, 0.01)

Leptin

-0.76 (-1.14, -0.39)

-0.21 (-0.62, 0.20)

-0.21 (-0.38, -0.05)

-0.01 (-0.16, 0.14)

Total Adiponectin

-0.32 (-0.56, -0.09)

-0.06 (-0.31, 0.19)

-0.14 (-0.27, -0.01)

-0.05 (-0.17, 0.07)

*adjusted for age, BMI, race, pain medications, depressive symptoms, radiographic knee OA

 

 


Disclosure: T. Neogi, None; L. Frey-Law, None; D. Misra, None; M. C. Nevitt, None; L. Arendt-Nielsen, None; E. K. Quinn, None; C. E. Lewis, None.

To cite this abstract in AMA style:

Neogi T, Frey-Law L, Misra D, Nevitt MC, Arendt-Nielsen L, Quinn EK, Lewis CE. Systemic Inflammation and Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/systemic-inflammation-and-pain-sensitization-in-knee-osteoarthritis-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-inflammation-and-pain-sensitization-in-knee-osteoarthritis-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology